(EQR) Equity Residential - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US29476L1070
Stock: Apartment, Rental, Property, Management
Total Rating 28
Risk 46
Buy Signal 0.46
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.21% |
| Yield on Cost 5y | 5.07% |
| Yield CAGR 5y | 3.37% |
| Payout Consistency | 93.3% |
| Payout Ratio | 2.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.0% |
| Relative Tail Risk | 2.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.41 |
| Alpha | -18.92 |
| Character TTM | |
|---|---|
| Beta | 0.642 |
| Beta Downside | 0.772 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.12% |
| CAGR/Max DD | 0.17 |
Description: EQR Equity Residential December 17, 2025
Equity Residential (NYSE:EQR) is a S&P 500-listed REIT that owns and manages 318 properties, totaling roughly 86,300 apartment units, primarily in high-density coastal metros and fast-growing markets such as Atlanta, Austin, Dallas/Fort Worth, and Denver.
Recent data (Q3 2024) show an occupancy rate of ~96% and a year-over-year rent growth of 4.2%, while the company reported adjusted FFO of $1.75 billion, reflecting a 7% increase despite rising borrowing costs. The multifamily sector remains supported by limited new supply in core cities, strong household formation trends, and a relatively inelastic demand curve that can absorb modest rent hikes.
For a deeper quantitative dive, explore ValueRay’s EQR dashboard to see the latest forward-looking metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.32 > 1.0 |
| NWC/Revenue: -41.12% < 20% (prev -38.76%; Δ -2.36% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.62b > Net Income 1.25b |
| Net Debt (-55.9m) to EBITDA (2.19b): -0.03 < 3 |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (388.7m) vs 12m ago -0.58% < -2% |
| Gross Margin: 46.34% > 18% (prev 0.64%; Δ 4571 % > 0.5%) |
| Asset Turnover: 14.81% > 50% (prev 14.05%; Δ 0.75% > 0%) |
| Interest Coverage Ratio: 3.75 > 6 (EBITDA TTM 2.19b / Interest Expense TTM 309.3m) |
Altman Z'' 0.30
| A: -0.06 (Total Current Assets 55.9m - Total Current Liabilities 1.32b) / Total Assets 20.75b |
| B: 0.06 (Retained Earnings 1.19b / Total Assets 20.75b) |
| C: 0.06 (EBIT TTM 1.16b / Avg Total Assets 20.84b) |
| D: 0.13 (Book Value of Equity 1.20b / Total Liabilities 9.34b) |
| Altman-Z'' Score: 0.30 = B |
Beneish M -2.51
| DSRI: 1.20 (Receivables 19.3m/15.4m, Revenue 3.09b/2.94b) |
| GMI: 1.37 (GM 46.34% / 63.64%) |
| AQI: 1.00 (AQ_t 0.98 / AQ_t-1 0.97) |
| SGI: 1.05 (Revenue 3.09b / 2.94b) |
| TATA: -0.02 (NI 1.25b - CFO 1.62b) / TA 20.75b) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
What is the price of EQR shares?
As of February 09, 2026, the stock is trading at USD 63.89 with a total of 3,802,297 shares traded.
Over the past week, the price has changed by +3.70%, over one month by +1.62%, over three months by +8.55% and over the past year by -6.07%.
Over the past week, the price has changed by +3.70%, over one month by +1.62%, over three months by +8.55% and over the past year by -6.07%.
Is EQR a buy, sell or hold?
Equity Residential has received a consensus analysts rating of 3.62.
Therefor, it is recommend to hold EQR.
- StrongBuy: 5
- Buy: 6
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EQR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.8 | 9.2% |
| Analysts Target Price | 69.8 | 9.2% |
| ValueRay Target Price | 66 | 3.2% |
EQR Fundamental Data Overview February 08, 2026
P/E Trailing = 22.2613
P/E Forward = 43.4783
P/S = 8.167
P/B = 2.1318
P/EG = 8.1454
Revenue TTM = 3.09b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 7.59b USD (from longTermDebt, last quarter)
Short Term Debt = 846.2m USD (from shortTermDebt, last quarter)
Debt = 8.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -55.9m USD (from netDebt column, last quarter)
Enterprise Value = 33.79b USD (25.14b + Debt 8.74b - CCE 93.1m)
Interest Coverage Ratio = 3.75 (Ebit TTM 1.16b / Interest Expense TTM 309.3m)
EV/FCF = 26.29x (Enterprise Value 33.79b / FCF TTM 1.29b)
FCF Yield = 3.80% (FCF TTM 1.29b / Enterprise Value 33.79b)
FCF Margin = 41.65% (FCF TTM 1.29b / Revenue TTM 3.09b)
Net Margin = 40.52% (Net Income TTM 1.25b / Revenue TTM 3.09b)
Gross Margin = 46.34% ((Revenue TTM 3.09b - Cost of Revenue TTM 1.66b) / Revenue TTM)
Gross Margin QoQ = -1.80% (prev 63.14%)
Tobins Q-Ratio = 1.63 (Enterprise Value 33.79b / Total Assets 20.75b)
Interest Expense / Debt = 0.94% (Interest Expense 81.9m / Debt 8.74b)
Taxrate = 0.09% (361.0k / 391.9m)
NOPAT = 1.16b (EBIT 1.16b * (1 - 0.09%))
Current Ratio = 0.04 (Total Current Assets 55.9m / Total Current Liabilities 1.32b)
Debt / Equity = 0.79 (Debt 8.74b / totalStockholderEquity, last quarter 11.04b)
Debt / EBITDA = -0.03 (Net Debt -55.9m / EBITDA 2.19b)
Debt / FCF = -0.04 (Net Debt -55.9m / FCF TTM 1.29b)
Total Stockholder Equity = 11.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.00% (Net Income 1.25b / Total Assets 20.75b)
RoE = 11.33% (Net Income TTM 1.25b / Total Stockholder Equity 11.04b)
RoCE = 6.23% (EBIT 1.16b / Capital Employed (Equity 11.04b + L.T.Debt 7.59b))
RoIC = 6.03% (NOPAT 1.16b / Invested Capital 19.22b)
WACC = 6.39% (E(25.14b)/V(33.89b) * Re(8.28%) + D(8.74b)/V(33.89b) * Rd(0.94%) * (1-Tc(0.00)))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF Debug] Terminal Value 84.63% ; FCFF base≈1.26b ; Y1≈1.30b ; Y5≈1.45b
Fair Price DCF = 97.42 (EV 37.01b - Net Debt -55.9m = Equity 37.07b / Shares 380.5m; r=6.39% [WACC]; 5y FCF grow 2.60% → 2.90% )
EPS Correlation: -31.31 | EPS CAGR: 11.40% | SUE: -0.46 | # QB: 0
Revenue Correlation: 97.45 | Revenue CAGR: 5.54% | SUE: 0.34 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.32 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=4
EPS current Year (2026-12-31): EPS=1.41 | Chg30d=-0.027 | Revisions Net=+0 | Growth EPS=+11.7% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=1.58 | Chg30d=+0.042 | Revisions Net=+1 | Growth EPS=+11.8% | Growth Revenue=+3.8%
P/E Forward = 43.4783
P/S = 8.167
P/B = 2.1318
P/EG = 8.1454
Revenue TTM = 3.09b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 7.59b USD (from longTermDebt, last quarter)
Short Term Debt = 846.2m USD (from shortTermDebt, last quarter)
Debt = 8.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -55.9m USD (from netDebt column, last quarter)
Enterprise Value = 33.79b USD (25.14b + Debt 8.74b - CCE 93.1m)
Interest Coverage Ratio = 3.75 (Ebit TTM 1.16b / Interest Expense TTM 309.3m)
EV/FCF = 26.29x (Enterprise Value 33.79b / FCF TTM 1.29b)
FCF Yield = 3.80% (FCF TTM 1.29b / Enterprise Value 33.79b)
FCF Margin = 41.65% (FCF TTM 1.29b / Revenue TTM 3.09b)
Net Margin = 40.52% (Net Income TTM 1.25b / Revenue TTM 3.09b)
Gross Margin = 46.34% ((Revenue TTM 3.09b - Cost of Revenue TTM 1.66b) / Revenue TTM)
Gross Margin QoQ = -1.80% (prev 63.14%)
Tobins Q-Ratio = 1.63 (Enterprise Value 33.79b / Total Assets 20.75b)
Interest Expense / Debt = 0.94% (Interest Expense 81.9m / Debt 8.74b)
Taxrate = 0.09% (361.0k / 391.9m)
NOPAT = 1.16b (EBIT 1.16b * (1 - 0.09%))
Current Ratio = 0.04 (Total Current Assets 55.9m / Total Current Liabilities 1.32b)
Debt / Equity = 0.79 (Debt 8.74b / totalStockholderEquity, last quarter 11.04b)
Debt / EBITDA = -0.03 (Net Debt -55.9m / EBITDA 2.19b)
Debt / FCF = -0.04 (Net Debt -55.9m / FCF TTM 1.29b)
Total Stockholder Equity = 11.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.00% (Net Income 1.25b / Total Assets 20.75b)
RoE = 11.33% (Net Income TTM 1.25b / Total Stockholder Equity 11.04b)
RoCE = 6.23% (EBIT 1.16b / Capital Employed (Equity 11.04b + L.T.Debt 7.59b))
RoIC = 6.03% (NOPAT 1.16b / Invested Capital 19.22b)
WACC = 6.39% (E(25.14b)/V(33.89b) * Re(8.28%) + D(8.74b)/V(33.89b) * Rd(0.94%) * (1-Tc(0.00)))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF Debug] Terminal Value 84.63% ; FCFF base≈1.26b ; Y1≈1.30b ; Y5≈1.45b
Fair Price DCF = 97.42 (EV 37.01b - Net Debt -55.9m = Equity 37.07b / Shares 380.5m; r=6.39% [WACC]; 5y FCF grow 2.60% → 2.90% )
EPS Correlation: -31.31 | EPS CAGR: 11.40% | SUE: -0.46 | # QB: 0
Revenue Correlation: 97.45 | Revenue CAGR: 5.54% | SUE: 0.34 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.32 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=4
EPS current Year (2026-12-31): EPS=1.41 | Chg30d=-0.027 | Revisions Net=+0 | Growth EPS=+11.7% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=1.58 | Chg30d=+0.042 | Revisions Net=+1 | Growth EPS=+11.8% | Growth Revenue=+3.8%